Cargando…

CBP/p300 Bromodomain Inhibitor–I–CBP112 Declines Transcription of the Key ABC Transporters and Sensitizes Cancer Cells to Chemotherapy Drugs

SIMPLE SUMMARY: Despite tremendous advances in cancer treatment, chemotherapy remains the first-line choice in many tumor types. The action of numerous chemotherapy drugs is limited by the occurrence of ABC proteins in cancer cell membranes, which remove medicines from cell compartments. In this pap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Strachowska, Magdalena, Gronkowska, Karolina, Michlewska, Sylwia, Robaszkiewicz, Agnieszka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467251/ https://www.ncbi.nlm.nih.gov/pubmed/34572840 http://dx.doi.org/10.3390/cancers13184614

Ejemplares similares

Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains
por: Hay, Duncan A., et al.
Publicado: (2014)

Activation of ABCC Genes by Cisplatin Depends on the CoREST Occurrence at Their Promoters in A549 and MDA-MB-231 Cell Lines
por: Sobczak, Maciej, et al.
Publicado: (2022)

Structure-Based Identification of Inhibitory Fragments Targeting the p300/CBP-Associated Factor Bromodomain
por: Chaikuad, Apirat, et al.
Publicado: (2016)

Histone acetyltransferases CBP/p300 in tumorigenesis and CBP/p300 inhibitors as promising novel anticancer agents
por: Chen, Qingjuan, et al.
Publicado: (2022)

CBP/p300 Bromodomains Regulate Amyloid-like Protein Aggregation upon Aberrant Lysine Acetylation
por: Olzscha, Heidi, et al.
Publicado: (2017)

Protein Lysine Acetylation by p300/CBP
por: Dancy, Beverley M., et al.
Publicado: (2015)

LSD1 Facilitates Pro-Inflammatory Polarization of Macrophages by Repressing Catalase
por: Sobczak, Maciej, et al.
Publicado: (2021)

Distinct modulation of IFNγ-induced transcription by BET bromodomain and catalytic P300/CBP inhibition in breast cancer
por: Hogg, Simon J., et al.
Publicado: (2022)

Curcumin, COX-2, and Protein p300/CBP
por: Jung, Ki Tae, et al.
Publicado: (2014)

Dimeric structure of p300/CBP associated factor
por: Shi, Shasha, et al.
Publicado: (2014)

Correction to Protein Lysine Acetylation by p300/CBP
por: Dancy, Beverley M., et al.
Publicado: (2016)

Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma
por: Conery, Andrew R, et al.
Publicado: (2016)

Genomic occupancy of the transcriptional co-activators p300 and CBP
por: Holmqvist, Per-Henrik, et al.
Publicado: (2013)

Epigenetic mechanisms to propagate histone acetylation by p300/CBP
por: Kikuchi, Masaki, et al.
Publicado: (2023)

Correction: Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma
por: Conery, Andrew R, et al.
Publicado: (2016)

p300/CBP as a Key Nutritional Sensor for Hepatic Energy Homeostasis and Liver Fibrosis
por: Yao, Weilei, et al.
Publicado: (2018)

Is histone acetylation the most important physiological function for CBP and p300?
por: Bedford, David C., et al.
Publicado: (2012)

HBZ inhibits the HAT activity of the cellular coactivators p300 and CBP
por: Wright, Diana, et al.
Publicado: (2011)

The prognostic capacities of CBP and p300 in locally advanced rectal cancer
por: Rühlmann, Felix, et al.
Publicado: (2019)

Discovery of novel CBP bromodomain inhibitors through TR-FRET-based high-throughput screening
por: Zhang, Feng-cai, et al.
Publicado: (2019)

Spatiotemporal expression of histone acetyltransferases, p300 and CBP, in developing embryonic hearts
por: Chen, Guozhen, et al.
Publicado: (2009)

CBP / p300-mediated acetylation of histone H3 on lysine 56
por: Das, Chandrima, et al.
Publicado: (2009)

Genome-wide assessment of differential roles for p300 and CBP in transcription regulation
por: Ramos, Yolande F. M., et al.
Publicado: (2010)

Lysine Acetyltransferases CBP and p300 as Therapeutic Targets in Cognitive and Neurodegenerative Disorders
por: Valor, Luis M, et al.
Publicado: (2013)

Salicylate, diflunisal and their metabolites inhibit CBP/p300 and exhibit anticancer activity
por: Shirakawa, Kotaro, et al.
Publicado: (2016)

Determination of the Role of CBP- and p300-Mediated Wnt Signaling on Colonic Cells
por: Bordonaro, Michael, et al.
Publicado: (2016)

Differential contribution of p300 and CBP to regulatory element acetylation in mESCs
por: Martire, Sara, et al.
Publicado: (2020)

Domain-Independent Inhibition of CBP/p300 Attenuates α-Synuclein Aggregation
por: Hlushchuk, Irena, et al.
Publicado: (2021)

Therapeutic targeting of p300/CBP HAT domain for the treatment of NUT midline carcinoma
por: Zhang, Xin, et al.
Publicado: (2020)

P300/CBP-Associated Factor Activates Cardiac Fibroblasts by SMAD2 Acetylation
por: Lim, Yongwoon, et al.
Publicado: (2021)

p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes
por: Martins, Vitor F., et al.
Publicado: (2022)

Structure of CbpA J-Domain Bound to the Regulatory Protein CbpM Explains Its Specificity and Suggests Evolutionary Link between CbpM and Transcriptional Regulators
por: Sarraf, Naghmeh S., et al.
Publicado: (2014)

Molecular dynamics simulations data of six compounds F3J-BRD4/CBP, EX1-BRD4/CBP, and E2T-BRD4/CBP
por: Wu, Shiliang, et al.
Publicado: (2021)

CBP Bromodomain Inhibition Rescues Mice From Lethal Sepsis Through Blocking HMGB1-Mediated Inflammatory Responses
por: Bi, Xiaowen, et al.
Publicado: (2021)

Fungal Rtt109 histone acetyltransferase is an unexpected structural homolog of metazoan p300/CBP
por: Tang, Yong, et al.
Publicado: (2008)

CBP/p300 and SIRT1 Are Involved in Transcriptional Regulation of S-Phase Specific Histone Genes
por: He, Hongpeng, et al.
Publicado: (2011)

CBP and p300 acetylate PCNA to link its degradation with nucleotide excision repair synthesis
por: Cazzalini, Ornella, et al.
Publicado: (2014)

Transcription Coactivators p300 and CBP Are Necessary for Photoreceptor-Specific Chromatin Organization and Gene Expression
por: Hennig, Anne K., et al.
Publicado: (2013)

Discovery of Spiro Oxazolidinediones as Selective, Orally Bioavailable Inhibitors of p300/CBP Histone Acetyltransferases
por: Michaelides, Michael R., et al.
Publicado: (2017)

Latent viruses can cause disease by disrupting the competition for the limiting factor p300/CBP
por: Polansky, Hanan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lln5u9bfshada92i4ho27uee65